Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway.
Adipolin is a novel adipokine with anti-inflammatory and glucose-lowering properties. Lower levels of adipolin are found in obese and diabetic mice. Polycystic ovary syndrome (PCOS) is a pro-inflammatory state associated with obesity and diabetes. To date, there are no human studies on adipolin. Therefore, we measured serum (ELISA) and adipose tissue adipolin mRNA expression (RT-PCR) and protein concentrations (western blotting) in PCOS and control subjects. We also investigated the ex vivo effect of glucose and metformin on adipolin protein production in human subcutaneous adipose tissue explants. We report novel data that serum and subcutaneous adipose tissue adipolin mRNA expression and protein concentrations were significantly lower in women with PCOS compared with control subjects. Furthermore, Spearman's rank analysis showed that serum adipolin concentrations were significantly negatively correlated with BMI, waist-to-hip ratio, and glucose (P<0.05). However, when subjected to multiple regression analysis, none of these variables were predictive of serum adipolin concentrations (P>0.05). Also, subcutaneous adipose tissue adipolin mRNA expression and protein concentrations were only significantly negatively correlated with glucose (P<0.05). No significant correlations were found with omental adipose tissue adipolin mRNA expression and protein concentrations (P>0.05). Moreover, glucose profoundly reduced and metformin significantly increased adipolin protein production in human adipose tissue explants respectively. Importantly, metformin's effects appear to be via the AMP-activated protein kinase signaling pathway.
Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
Bee K
BK
Tan
Jing
J
Chen
Raghu
R
Adya
Manjunath
M
Ramanjaneya
Vanlata
V
Patel
Harpal S
HS
Randeva
D055372:AMP-Activated Protein Kinases / Q000502:physiology*; D054392:Adipokines / Q000378:metabolism*; D000328:Adult; D015992:Body Mass Index; D016022:Case-Control Studies; D005260:Female; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D008687:Metformin / Q000494:pharmacology*; D011085:Polycystic Ovary Syndrome / Q000378:metabolism* / Q000503:physiopathology; D012333:RNA, Messenger / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D050151:Subcutaneous Fat / Q000378:metabolism*; D049629:Waist-Hip Ratio
D054392:Adipokines; C584654:C1QTNF12 protein, human; D007004:Hypoglycemic Agents; D012333:RNA, Messenger; D008687:Metformin; D055372:AMP-Activated Protein Kinases; D005947:Glucose
adipokine; adipolin; metformin; polycystic ovary syndrome